0%
0%
0%
0%
0%
About Revolution Medicines, Inc
Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO
Mark A. Goldsmith
Website
revmed.com
Headquarters
Redwood City
Employees
246
ISIN
US76155X1000
Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
RVMD - a biotech that ending consolidation?
Fundamentals: Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment. Average 1 year target from analysts = 54.
Technical: To allow the stock some fluctuation the stop
RVMDClassics of the genre. A young and beautiful company that has everything ready to make friends with you, that is, the Triangle pattern, which has already been formed and broken up. Now the price will move along the indicated arrows and reach the main target of the trade of 72.44 dollars (an increase
RVMD Revolution Medicines, Inc. - LONG$RVMD still very cheap imo...buy and hold, LT hold. Next MRTX ?
See all ideas
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Gain new superpowers
Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world.Learn moreCurated watchlists where RVMD is featured.
